In addition, other trials also found significant reductions in HbA1c (hemoglobin-A1c: glucose linked to hemoglobin in red blood cells), total cholesterol, and triglycerides (87)
These comorbidities are interlinked via shared immunopathogenic mechanisms, notably chronic low-grade inflammation driven by Th1/Th17 cytokines such as TNF, IL-6, and IL-17
This dual-action approach enhances insulin sensitivity and further reduces appetite and fat storage, often leading to even more substantial weight loss than GLP-1-only therapies
Song, S
Administration of liraglutide, still at nanomolar concentrations, to bone marrow macrophages or the pre-osteoclast Raw264.7 cell line resulted in a reduction in osteoclast formation and osteoclast-mediated resorption [53], suggesting a decoupling effect on bone formation and resorption
Why the heart and liver benefit, even without direct targets Habegger says one of the most striking findings from large clinical trials is that GLP-1 drugs reduce the risk of heart attacks, strokes and cardiovascular death